Skip to main content
SpringerLink
Log in

Locus coeruleus

  • Review
  • Published:
Cell and Tissue Research Aims and scope Submit manuscript

Abstract

The locus coeruleus (LC) contains norepinephrine (NE)-synthesizing neurons that send diffuse projections throughout the central nervous system. The LC-NE system has a major role in arousal, attention and stress responses. In the brain, NE may also contribute to long-term synaptic plasticity, pain modulation, motor control, energy homeostasis and control of local blood flow. The LC is severely affected in neurodegenerative disorders including Parkinson disease (PD). Involvement of the noradrenergic neurons of the LC precedes that of dopaminergic neurons of the substantia nigra pars compacta and has been increasingly recognized as a potential major contributor to cognitive manifestations in early PD, particularly impaired attention. Abnormal noradrenergic signaling may also potentially contribute to motor manifestations of the disease.This makes the LC-NE system a major contributor to the pathobiology and potential target for therapy of PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Arcos D, Sierra A, Nunez A, Flores G, Aceves J, Arias-Montano JA (2003) Noradrenaline increases the firing rate of a subpopulation of rat subthalamic neurones through the activation of alpha 1-adrenoceptors. Neuropharmacology 45:1070–1079

    Article  PubMed  CAS  Google Scholar 

  • Arnsten AF, Goldman-Rakic PS (1984) Selective prefrontal cortical projections to the region of the locus coeruleus and raphe nuclei in the rhesus monkey. Brain res 306:9–18

    Article  PubMed  CAS  Google Scholar 

  • Arnsten AF, Wang MJ, Paspalas CD (2012) Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses. Neuron 76:223–239

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Aston-Jones G, Cohen JD (2005) An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu Rev Neurosci 28:403–450

    Article  PubMed  CAS  Google Scholar 

  • Atzori M, Cuevas-Olguin R, Esquivel-Rendon E, Garcia-Oscos F, Salgado-Delgado RC, Saderi N, Miranda-Morales M, Trevino M, Pineda JC, Salgado H (2016) Locus Ceruleus norepinephrine release: a central regulator of CNS Spatio-temporal activation? Front Synaptic Neurosci 8:25

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Belujon P, Bezard E, Taupignon A, Bioulac B, Benazzouz A (2007) Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats. J Neurosci 27:9595–9606

    Article  PubMed  CAS  Google Scholar 

  • Benarroch EE (2009) The locus ceruleus norepinephrine system: functional organization and potential clinical significance. Neurology 73:1699–1704

    Article  PubMed  Google Scholar 

  • Berridge CW, Waterhouse BD (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42:33–84

    Article  PubMed  Google Scholar 

  • Berridge CW, Stratford TL, Foote SL, Kelley AE (1997) Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse 27:230–241

    Article  PubMed  CAS  Google Scholar 

  • Bezard E, Brefel C, Tison F, Peyro-Saint-Paul H, Ladure P, Rascol O, Gross CE (1999) Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey. Prog Neuro-Psychopharmacol Biol Psychiatry 23:1237–1246

    Article  CAS  Google Scholar 

  • Bouret S, Sara SJ (2005) Network reset: a simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci 28:574–582

    Article  PubMed  CAS  Google Scholar 

  • Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211

    Article  PubMed  Google Scholar 

  • Brunnstrom H, Friberg N, Lindberg E, Englund E (2011) Differential degeneration of the locus coeruleus in dementia subtypes. Clin Neuropathol 30:104–110

    Article  PubMed  CAS  Google Scholar 

  • Carey MR, Regehr WG (2009) Noradrenergic control of associative synaptic plasticity by selective modulation of instructive signals. Neuron 62:112–122

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Carter ME, Adamantidis A, Ohtsu H, Deisseroth K, de Lecea L (2009) Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. J Neurosci 29:10939–10949

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chan CS, Gertler TS, Surmeier DJ (2010) A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson’s disease. Mov Disord 25(Suppl 1):S63–S70

    Article  PubMed  Google Scholar 

  • Chan-Palay V, Asan E (1989) Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression. J Comp Neurol 287:357–372

    Article  PubMed  CAS  Google Scholar 

  • Chen X, Huddleston DE, Langley J, Ahn S, Barnum CJ, Factor SA, Levey AI, Hu X (2014) Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. Magn Reson Imaging 32:1301–1306

    Article  PubMed  Google Scholar 

  • Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5:374–381

    Article  PubMed  CAS  Google Scholar 

  • Chudasama Y, Robbins TW (2006) Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol 73:19–38

    Article  PubMed  CAS  Google Scholar 

  • Corbetta M, Patel G, Shulman GL (2008) The reorienting system of the human brain: from environment to theory of mind. Neuron 58:306–324

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Dahlstrom A, Fuxe K (1964) Localization of monoamines in the lower brain stem. Experientia 20:398–399

    Article  PubMed  CAS  Google Scholar 

  • Dayan P, Yu AJ (2006) Phasic norepinephrine: a neural interrupt signal for unexpected events. Network 17:335–350

    Article  PubMed  Google Scholar 

  • Del Tredici K, Braak H (2012) Lewy pathology and neurodegeneration in premotor Parkinson’s disease. Mov Disord 27:597–607

    Article  PubMed  Google Scholar 

  • Del Tredici K, Braak H (2013) Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson’s disease-related dementia. J Neurol Neurosurg Psychiatry 84:774–783

    Article  PubMed  Google Scholar 

  • Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H (2002) Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426

    Article  PubMed  Google Scholar 

  • Delaville C, Deurwaerdere PD, Benazzouz A (2011) Noradrenaline and Parkinson’s disease. Front Syst Neurosci 5:31

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Delaville C, Zapata J, Cardoit L, Benazzouz A (2012) Activation of subthalamic alpha 2 noradrenergic receptors induces motor deficits as a consequence of neuronal burst firing. Neurobiol Dis 47:322–330

    Article  PubMed  CAS  Google Scholar 

  • Domino EF, Ni L, Colpaert F, Marien M (2003) Effects of (+/−)-idazoxan alone and in combination with L-DOPA methyl ester in MPTP-induced hemiparkinsonian monkeys. Receptors Channels 9:335–338

    Article  PubMed  CAS  Google Scholar 

  • Dong CJ, Guo Y, Agey P, Wheeler L, Hare WA (2008) Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity. Invest Ophthalmol Vis Sci 49:4515–4522

    Article  PubMed  Google Scholar 

  • Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW (1989) Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson’s disease: evidence for a specific attentional dysfunction. Neuropsychologia 27:1329–1343

    Article  PubMed  CAS  Google Scholar 

  • Downs JL, Dunn MR, Borok E, Shanabrough M, Horvath TL, Kohama SG, Urbanski HF (2007) Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque. Neurobiol Aging 28:1286–1295

    Article  PubMed  CAS  Google Scholar 

  • Ehgoetz Martens KA, Lewis SJ (2016) Pathology of behavior in PD: what is known and what is not? J Neurol Sci

  • Ehrminger M, Latimier A, Pyatigorskaya N, Garcia-Lorenzo D, Leu-Semenescu S, Vidailhet M, Lehericy S, Arnulf I (2016) The coeruleus/subcoeruleus complex in idiopathic rapid eye movement sleep behaviour disorder. Brain 139:1180–1188

    Article  PubMed  Google Scholar 

  • Foote SL, Morrison JH (1987) Extrathalamic modulation of cortical function. Annu Rev Neurosci 10:67–95

    Article  PubMed  CAS  Google Scholar 

  • Fu Y, Paxinos G, Watson C, Halliday GM (2016) The substantia nigra and ventral tegmental dopaminergic neurons from development to degeneration. J Chem Neuroanat 76:98–107

    Article  PubMed  CAS  Google Scholar 

  • Garcia-Lorenzo D, Longo-Dos Santos C, Ewenczyk C, Leu-Semenescu S, Gallea C, Quattrocchi G, Pita Lobo P, Poupon C, Benali H, Arnulf I et al (2013) The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease. Brain 136:2120–2129

    Article  PubMed  PubMed Central  Google Scholar 

  • Gaspar P, Berger B, Febvret A, Vigny A, Henry JP (1989) Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J Comp Neurol 279:249–271

    Article  PubMed  CAS  Google Scholar 

  • German DC, Manaye KF, White CL 3rd, Woodward DJ, McIntire DD, Smith WK, Kalaria RN, Mann DM (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667–676

    Article  PubMed  CAS  Google Scholar 

  • Ginsberg SD, Hof PR, Young WG, Morrison JH (1993) Noradrenergic innervation of the hypothalamus of rhesus monkeys: distribution of dopamine-beta-hydroxylase immunoreactive fibers and quantitative analysis of varicosities in the paraventricular nucleus. J Comp Neurol 327:597–611

    Article  PubMed  CAS  Google Scholar 

  • Gompf HS, Mathai C, Fuller PM, Wood DA, Pedersen NP, Saper CB, Lu J (2010) Locus ceruleus and anterior cingulate cortex sustain wakefulness in a novel environment. J Neurosci 30:14543–14551

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Guo A, Feng JY, Li J, Ding N, Li YJ, Qiu DL, Piao RL, Chu CP (2016) Effects of norepinephrine on spontaneous firing activity of cerebellar Purkinje cells in vivo in mice. Neurosci Lett 629:262–266

    Article  PubMed  CAS  Google Scholar 

  • Hagena H, Hansen N, Manahan-Vaughan D (2016) Beta-adrenergic control of hippocampal function: Subserving the choreography of synaptic information storage and memory. Cereb Cortex 26:1349–1364

    Article  PubMed  PubMed Central  Google Scholar 

  • Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RG, Howe PR, Blessing WW, Geffen LB (1990) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson’s disease. Ann Neurol 27:373–385

    Article  PubMed  CAS  Google Scholar 

  • Holloway BB, Stornetta RL, Bochorishvili G, Erisir A, Viar KE, Guyenet PG (2013) Monosynaptic glutamatergic activation of locus coeruleus and other lower brainstem noradrenergic neurons by the C1 cells in mice. J Neurosci 33:18792–18805

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hurlemann R, Walter H, Rehme AK, Kukolja J, Santoro SC, Schmidt C, Schnell K, Musshoff F, Keysers C, Maier W et al (2010) Human amygdala reactivity is diminished by the beta-noradrenergic antagonist propranolol. Psychol Med 40:1839–1848

    Article  PubMed  CAS  Google Scholar 

  • Isaias IU, Marotta G, Pezzoli G, Sabri O, Schwarz J, Crenna P, Classen J, Cavallari P (2011) Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease. BMC Neurol 11:88

    Article  PubMed  PubMed Central  Google Scholar 

  • Isaias IU, Trujillo P, Summers P, Marotta G, Mainardi L, Pezzoli G, Zecca L, Costa A (2016) Neuromelanin imaging and dopaminergic loss in Parkinson’s disease. Front Aging Neurosci 8:196

    Article  PubMed  PubMed Central  Google Scholar 

  • Jhang KA, Lee EO, Kim HS, Chong YH (2014) Norepinephrine provides short-term neuroprotection against Abeta1-42 by reducing oxidative stress independent of Nrf2 activation. Neurobiol Aging 35:2465–2473

    Article  PubMed  CAS  Google Scholar 

  • Jiang L, Chen SH, Chu CH, Wang SJ, Oyarzabal E, Wilson B, Sanders V, Xie K, Wang Q, Hong JS (2015) A novel role of microglial NADPH oxidase in mediating extra-synaptic function of norepinephrine in regulating brain immune homeostasis. Glia 63:1057–1072

    Article  PubMed  PubMed Central  Google Scholar 

  • Johnson PL, Federici LM, Fitz SD, Renger JJ, Shireman B, Winrow CJ, Bonaventure P, Shekhar A (2015) Orexin 1 and 2 receptor involvement in Co2 -induced panic-associated behavior and autonomic responses. Depress Anxiety 32:671–683

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kawamoto Y, Ito H, Ayaki T, Takahashi R (2014) Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson’s disease and dementia with Lewy bodies. Brain Res 1571:39–48

    Article  PubMed  CAS  Google Scholar 

  • Kehagia AA, Housden CR, Regenthal R, Barker RA, Muller U, Rowe J, Sahakian BJ, Robbins TW (2014) Targeting impulsivity in Parkinson’s disease using atomoxetine. Brain 137:1986–1997

    Article  PubMed  PubMed Central  Google Scholar 

  • Keren NI, Taheri S, Vazey EM, Morgan PS, Granholm AC, Aston-Jones GS, Eckert MA (2015) Histologic validation of locus coeruleus MRI contrast in post-mortem tissue. NeuroImage 113:235–245

    Article  PubMed  PubMed Central  Google Scholar 

  • Kim MA, Lee HS, Lee BY, Waterhouse BD (2004) Reciprocal connections between subdivisions of the dorsal raphe and the nuclear core of the locus coeruleus in the rat. Brain Res 1026:56–67

    Article  PubMed  CAS  Google Scholar 

  • Kim S, Park JM, Moon J, Choi HJ (2014) Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine beta-hydroxylase and is associated with abnormal adaptive responses to immobilization stress. Exp Neurol 252:63–74

    Article  PubMed  CAS  Google Scholar 

  • Konishi S, Hirose S, Jimura K, Chikazoe J, Watanabe T, Kimura HM, Miyashita Y (2010) Medial prefrontal activity during shifting under novel situations. Neurosci Lett 484:182–186

    Article  PubMed  CAS  Google Scholar 

  • Krishna V, Elias G, Sammartino F, Basha D, King NK, Fasano A, Munhoz R, Kalia SK, Hodaie M, Venkatraghavan L et al (2015) The effect of dexmedetomidine on the firing properties of STN neurons in Parkinson’s disease. Eur J Neurosci 42:2070–2077

    Article  PubMed  Google Scholar 

  • Lees AJ, Smith E (1983) Cognitive deficits in the early stages of Parkinson’s disease. Brain 106(Pt 2):257–270

    Article  PubMed  Google Scholar 

  • Leichnetz GR (1986) Afferent and efferent connections of the dorsolateral precentral gyrus (area 4, hand/arm region) in the macaque monkey, with comparisons to area 8. J Comp Neurol 254:460–492

    Article  PubMed  CAS  Google Scholar 

  • Lewis DA, Morrison JH (1989) Noradrenergic innervation of monkey prefrontal cortex: a dopamine-beta-hydroxylase immunohistochemical study. J Comp Neurol 282:317–330

    Article  PubMed  CAS  Google Scholar 

  • Lewitt PA (2012) Norepinephrine: the next therapeutics frontier for Parkinson’s disease. Transl Neurodegener 1:4

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lim EP, Tan CH, Jay TM, Dawe GS (2010) Locus coeruleus stimulation and noradrenergic modulation of hippocampo-prefrontal cortex long-term potentiation. Int J Neuropsychopharmacol 13:1219–1231

    Article  PubMed  CAS  Google Scholar 

  • Lindvall O, Bjorklund A (1974) The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol Scand Suppl 412:1–48

    PubMed  CAS  Google Scholar 

  • Lippiello P, Hoxha E, Volpicelli F, Lo Duca G, Tempia F, Miniaci MC (2015) Noradrenergic modulation of the parallel fiber-Purkinje cell synapse in mouse cerebellum. Neuropharmacology 89:33–42

    Article  PubMed  CAS  Google Scholar 

  • Liu X, Ye K, Weinshenker D (2015) Norepinephrine protects against amyloid-beta toxicity via TrkB. J Alzheimers Dis 44:251–260

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Luppi PH, Clement O, Valencia Garcia S, Brischoux F, Fort P (2013) New aspects in the pathophysiology of rapid eye movement sleep behavior disorder: the potential role of glutamate, gamma-aminobutyric acid, and glycine. Sleep Med 14:714–718

    Article  PubMed  Google Scholar 

  • Madrigal JL, Kalinin S, Richardson JC, Feinstein DL (2007) Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta. J Neurochem 103:2092–2101

    Article  PubMed  CAS  Google Scholar 

  • Malhotra PA, Parton AD, Greenwood R, Husain M (2006) Noradrenergic modulation of space exploration in visual neglect. Ann Neurol 59:186–190

    Article  PubMed  CAS  Google Scholar 

  • Marin C, Aguilar E, Bonastre M (2008) Effect of locus coeruleus denervation on levodopa-induced motor fluctuations in hemiparkinsonian rats. J Neural Transm (Vienna) 115:1133–1139

    Article  CAS  Google Scholar 

  • Masilamoni GJ, Groover O, Smith Y (2016) Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys. Neurobiol Dis

  • Matschke LA, Bertoune M, Roeper J, Snutch TP, Oertel WH, Rinne S, Decher N (2015) A concerted action of L- and T-type ca(2+) channels regulates locus coeruleus pacemaking. Mol Cell Neurosci 68:293–302

    Article  PubMed  CAS  Google Scholar 

  • McCormick DA (1992) Neurotransmitter actions in the thalamus and cerebral cortex. J Clin Neurophysiol 9:212–223

    Article  PubMed  CAS  Google Scholar 

  • McGaughy J, Ross RS, Eichenbaum H (2008) Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting. Neuroscience 153:63–71

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • McMillan PJ, White SS, Franklin A, Greenup JL, Leverenz JB, Raskind MA, Szot P (2011) Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson’s disease and Alzheimer’s disease. Brain Res 1373:240–252

    Article  PubMed  CAS  Google Scholar 

  • Mevawalla N, Fung V, Morris J, Halliday GM (2009) Unilateral rest tremor in vascular parkinsonism associated with a contralateral lesion of the locus coeruleus. Mov Disord 24:1242–1244

    Article  PubMed  Google Scholar 

  • Miller MA, Kolb PE, Leverenz JB, Peskind ER, Raskind MA (1999) Preservation of noradrenergic neurons in the locus ceruleus that coexpress galanin mRNA in Alzheimer’s disease. J Neurochem 73:2028–2036

    PubMed  CAS  Google Scholar 

  • Miller IN, Neargarder S, Risi MM, Cronin-Golomb A (2013) Frontal and posterior subtypes of neuropsychological deficit in Parkinson’s disease. Behav Neurosci 127:175–183

    Article  PubMed  PubMed Central  Google Scholar 

  • Moron JA, Brockington A, Wise RA, Rocha BA, Hope BT (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22:389–395

    Article  PubMed  CAS  Google Scholar 

  • Morrison JH, Foote SL (1986) Noradrenergic and serotoninergic innervation of cortical, thalamic, and tectal visual structures in old and new world monkeys. J Comp Neurol 243:117–138

    Article  PubMed  CAS  Google Scholar 

  • Morrison JH, Foote SL, O’Connor D, Bloom FE (1982) Laminar, tangential and regional organization of the noradrenergic innervation of monkey cortex: dopamine-beta-hydroxylase immunohistochemistry. Brain Res Bull 9:309–319

    Article  PubMed  CAS  Google Scholar 

  • Nystrom B, Olson L, Ungerstedt U (1972) Noradrenaline nerve terminals in human cerebral cortices: first histochemical evidence. Science 176:924–926

    Article  PubMed  CAS  Google Scholar 

  • O’Donnell J, Ding F, Nedergaard M (2015) Distinct functional states of astrocytes during sleep and wakefulness: is norepinephrine the master regulator? Curr Sleep Med Rep 1:1–8

    Article  PubMed  PubMed Central  Google Scholar 

  • Ohtsuka C, Sasaki M, Konno K, Koide M, Kato K, Takahashi J, Takahashi S, Kudo K, Yamashita F, Terayama Y (2013) Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson’s disease using neuromelanin-sensitive MR imaging. Neurosci Lett 541:93–98

    Article  PubMed  CAS  Google Scholar 

  • Ohtsuka C, Sasaki M, Konno K, Kato K, Takahashi J, Yamashita F, Terayama Y (2014) Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord 20:755–760

    Article  PubMed  Google Scholar 

  • Ostock CY, Lindenbach D, Goldenberg AA, Kampton E, Bishop C (2014) Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat. Behav Brain Res 270:75–85

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Owen AM, Roberts AC, Hodges JR, Summers BA, Polkey CE, Robbins TW (1993) Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson’s disease. Brain 116(Pt 5):1159–1175

    Article  PubMed  Google Scholar 

  • Pammer C, Gorcs T, Palkovits M (1990) Peptidergic innervation of the locus coeruleus cells in the human brain. Brain Res 515:247–255

    Article  PubMed  CAS  Google Scholar 

  • Pan MK, Kuo SH, Tai CH, Liou JY, Pei JC, Chang CY, Wang YM, Liu WC, Wang TR, Lai WS et al (2016) Neuronal firing patterns outweigh circuitry oscillations in parkinsonian motor control. J Clin Invest 126:4516–4526

    Article  PubMed  PubMed Central  Google Scholar 

  • Patel NJ, Chen MJ, Russo-Neustadt AA (2010) Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons. Eur J Pharmacol 633:1–9

    Article  PubMed  CAS  Google Scholar 

  • Patt S, Gerhard L (1993) A Golgi study of human locus coeruleus in normal brains and in Parkinson’s disease. Neuropathol Appl Neurobiol 19:519–523

    Article  PubMed  CAS  Google Scholar 

  • Pavese N, Rivero-Bosch M, Lewis SJ, Whone AL, Brooks DJ (2011) Progression of monoaminergic dysfunction in Parkinson’s disease: a longitudinal 18F-dopa PET study. NeuroImage 56:1463–1468

    Article  PubMed  CAS  Google Scholar 

  • Perez V, Marin C, Rubio A, Aguilar E, Barbanoj M, Kulisevsky J (2009) Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances. J Neural Transm (Vienna) 116:1257–1266

    Article  CAS  Google Scholar 

  • Philippens IH, Joosen MJ, Ahnaou A, Andres I, Drinkenburg WP (2014) Anti-Parkinson effects of a selective alpha2C-adrenoceptor antagonist in the MPTP marmoset model. Behav Brain Res 269:81–86

    Article  PubMed  CAS  Google Scholar 

  • Pifl C, Kish SJ, Hornykiewicz O (2012) Thalamic noradrenaline in Parkinson’s disease: deficits suggest role in motor and non-motor symptoms. Mov Disord 27:1618–1624

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Radley JJ, Williams B, Sawchenko PE (2008) Noradrenergic innervation of the dorsal medial prefrontal cortex modulates hypothalamo-pituitary-adrenal responses to acute emotional stress. J Neurosci 28:5806–5816

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Rascol O, Arnulf I, Peyro-Saint Paul H, Brefel-Courbon C, Vidailhet M, Thalamas C, Bonnet AM, Descombes S, Bejjani B, Fabre N et al (2001) Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson’s disease. Mov Disord 16:708–713

    Article  PubMed  CAS  Google Scholar 

  • Remy P, Doder M, Lees A, Turjanski N, Brooks D (2005) Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128:1314–1322

    Article  PubMed  Google Scholar 

  • Ressler KJ, Nemeroff CB (2001) Role of norepinephrine in the pathophysiology of neuropsychiatric disorders. CNS Spectr 6(663–666):670

    Google Scholar 

  • Rommelfanger KS, Weinshenker D (2007) Norepinephrine: the redheaded stepchild of Parkinson’s disease. Biochem Pharmacol 74:177–190

    Article  PubMed  CAS  Google Scholar 

  • Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D (2007) Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc Natl Acad Sci U S a 104:13804–13809

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Roozendaal B, McGaugh JL (2011) Memory modulation. Behav Neurosci 125:797–824

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sadikot AF, Parent A (1990) The monoaminergic innervation of the amygdala in the squirrel monkey: an immunohistochemical study. Neuroscience 36:431–447

    Article  PubMed  CAS  Google Scholar 

  • Sanchez-Padilla J, Guzman JN, Ilijic E, Kondapalli J, Galtieri DJ, Yang B, Schieber S, Oertel W, Wokosin D, Schumacker PT et al (2014) Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase. Nat Neurosci 17:832–840

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sawada Y, Nishio Y, Suzuki K, Hirayama K, Takeda A, Hosokai Y, Ishioka T, Itoyama Y, Takahashi S, Fukuda H et al (2012) Attentional set-shifting deficit in Parkinson’s disease is associated with prefrontal dysfunction: an FDG-PET study. PLoS ONE 7:e38498

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Schambra UB, Mackensen GB, Stafford-Smith M, Haines DE, Schwinn DA (2005) Neuron specific alpha-adrenergic receptor expression in human cerebellum: implications for emerging cerebellar roles in neurologic disease. Neuroscience 135:507–523

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Schwarz ST, Xing Y, Tomar P, Bajaj N, Auer DP (2016) In vivo assessment of brainstem depigmentation in Parkinson disease: potential as a severity marker for multicenter studies. Radiology 160662

  • Seidel K, Mahlke J, Siswanto S, Kruger R, Heinsen H, Auburger G, Bouzrou M, Grinberg LT, Wicht H, Korf HW et al (2015) The brainstem pathologies of Parkinson’s disease and dementia with Lewy bodies. Brain Pathol 25:121–135

    Article  PubMed  Google Scholar 

  • Seppi K, Weintraub D, Coelho M, Perez-Lloret S, Fox SH, Katzenschlager R, Hametner EM, Poewe W, Rascol O, Goetz CG et al (2011) The Movement Disorder Society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson’s disease. Mov Disord 26(Suppl 3):S42–S80

    Article  PubMed  PubMed Central  Google Scholar 

  • Sharma Y, Xu T, Graf WM, Fobbs A, Sherwood CC, Hof PR, Allman JM, Manaye KF (2010) Comparative anatomy of the locus coeruleus in humans and nonhuman primates. J Comp Neurol 518:963–971

    Article  PubMed  PubMed Central  Google Scholar 

  • Shin E, Rogers JT, Devoto P, Bjorklund A, Carta M (2014) Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease. Exp Neurol 257:25–38

    Article  PubMed  CAS  Google Scholar 

  • Sotiriou E, Vassilatis DK, Vila M, Stefanis L (2010) Selective noradrenergic vulnerability in alpha-synuclein transgenic mice. Neurobiol Aging 31:2103–2114

    Article  PubMed  CAS  Google Scholar 

  • Srinivasan J, Schmidt WJ (2003) Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats. Eur J Neurosci 17:2586–2592

    Article  PubMed  CAS  Google Scholar 

  • Strange BA, Dolan RJ (2004) Beta-adrenergic modulation of emotional memory-evoked human amygdala and hippocampal responses. Proc Natl Acad Sci U S A 101:11454–11458

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Syed A, Chatfield M, Matthews F, Harrison P, Brayne C, Esiri MM (2005) Depression in the elderly: pathological study of raphe and locus ceruleus. Neuropathol Appl Neurobiol 31:405–413

    Article  PubMed  CAS  Google Scholar 

  • Taylor TN, Alter SP, Wang M, Goldstein DS, Miller GW (2014) Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus. Neuropharmacology 76 Pt A:97–105

  • Usher M, Cohen JD, Servan-Schreiber D, Rajkowski J, Aston-Jones G (1999) The role of locus coeruleus in the regulation of cognitive performance. Science 283:549–554

    Article  PubMed  CAS  Google Scholar 

  • van Dijk KD, Berendse HW, Drukarch B, Fratantoni SA, Pham TV, Piersma SR, Huisman E, Breve JJ, Groenewegen HJ, Jimenez CR et al (2012) The proteome of the locus ceruleus in Parkinson’s disease: relevance to pathogenesis. Brain Pathol 22:485–498

    Article  PubMed  CAS  Google Scholar 

  • Vazey EM, Aston-Jones G (2012) The emerging role of norepinephrine in cognitive dysfunctions of Parkinson’s disease. Front Behav Neurosci 6:48

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Vogt BA, Hof PR, Friedman DP, Sikes RW, Vogt LJ (2008) Norepinephrinergic afferents and cytology of the macaque monkey midline, mediodorsal, and intralaminar thalamic nuclei. Brain Struct Funct 212:465–479

    Article  PubMed  PubMed Central  Google Scholar 

  • Wakamatsu K, Tabuchi K, Ojika M, Zucca FA, Zecca L, Ito S (2015) Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus. J Neurochem 135:768–776

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Wang T, Zhang QJ, Liu J, Wu ZH, Wang S (2009) Firing activity of locus coeruleus noradrenergic neurons increases in a rodent model of parkinsonism. Neurosci Bull 25:15–20

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang X, Pinol RA, Byrne P, Mendelowitz D (2014) Optogenetic stimulation of locus ceruleus neurons augments inhibitory transmission to parasympathetic cardiac vagal neurons via activation of brainstem alpha1 and beta1 receptors. J Neurosci 34:6182–6189

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Waterhouse BD, Devilbiss D, Fleischer D, Sessler FM, Simpson KL (1998) New perspectives on the functional organization and postsynaptic influences of the locus ceruleus efferent projection system. Adv Pharmacol 42:749–754

    Article  PubMed  CAS  Google Scholar 

  • Weitemier AZ, McHugh TJ (2016) Noradrenergic modulation of evoked dopamine release and pH shift in the mouse dorsal hippocampus and ventral striatum. Brain Res

  • Westlund KN, Coulter JD (1980) Descending projections of the locus coeruleus and subcoeruleus/medial parabrachial nuclei in monkey: axonal transport studies and dopamine-beta-hydroxylase immunocytochemistry. Brain Res 2:235–264

    Article  PubMed  CAS  Google Scholar 

  • Westlund KN, Craig AD (1996) Association of spinal lamina I projections with brainstem catecholamine neurons in the monkey. Exp Brain Res 110:151–162

    Article  PubMed  CAS  Google Scholar 

  • Wilson RS, Nag S, Boyle PA, Hizel LP, Yu L, Buchman AS, Shah RC, Schneider JA, Arnold SE, Bennett DA (2013) Brainstem aminergic nuclei and late-life depressive symptoms. JAMA Psychiatry 70:1320–1328

    Article  PubMed  Google Scholar 

  • Xing B, Li YC, Gao WJ (2016) Norepinephrine versus dopamine and their interaction in modulating synaptic function in the prefrontal cortex. Brain Res 1641:217–233

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yao N, Wu Y, Zhou Y, Ju L, Liu Y, Ju R, Duan D, Xu Q (2015) Lesion of the locus coeruleus aggravates dopaminergic neuron degeneration by modulating microglial function in mouse models of Parkinsons disease. Brain Res 1625:255–274

    Article  PubMed  CAS  Google Scholar 

  • Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ et al (2015) Improving response inhibition in Parkinson’s disease with atomoxetine. Biol Psychiatry 77:740–748

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341

    Article  PubMed  Google Scholar 

  • Zucca FA, Segura-Aguilar J, Ferrari E, Munoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L (2015) Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson’s disease. Prog Neurobiol

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Mayo Clinic, 200 First Street SW (Southwest), Rochester, MN, 55905, USA

    Eduardo E. Benarroch

Authors
  1. Eduardo E. Benarroch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduardo E. Benarroch.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benarroch, E.E. Locus coeruleus. Cell Tissue Res 373, 221–232 (2018). https://doi.org/10.1007/s00441-017-2649-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00441-017-2649-1

Keywords

Search

Navigation